Hi Lisa
Nicht nur da sollte man gucken
Next page of Clinical Trials »
*
1
Recruiting
Temsirolimus and Radiation for Non-Small Cell Lung Cancer
Condition(s): Carcinoma, Non-Small-Cell Lung
*
2
Recruiting
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
*
3
Recruiting
Erlotinib and Temsirolimus for Solid Tumors
Condition(s): Solid Tumors
*
4
Active, not recruiting
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Condition(s): Resistant Solid Malignancies
*
5
Recruiting
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Condition(s): Colorectal Cancer; Colorectal Adenocarcinoma
*
6
Recruiting
IMC-A12 in Combination With Temsirolimus (CCI-779) in Patients With Advanced Cancers
Condition(s): Advanced Cancers; Metastatic Cancer
*
7
Recruiting
Temsirolimus With or Without Temozolomide in Treating Patients With Primary or Metastatic Brain Tumors
Condition(s): Brain and Central Nervous System Tumors; Metastatic Cancer
*
8
Recruiting
Doxil, Bevacizumab and Temsirolimus Trial
Condition(s): Advanced Cancer
*
9
Active, not recruiting
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Condition(s): Resistant Solid Malignancies
*
10
Not yet recruiting
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition(s): Squamous Cell Carcinoma of the Head and Neck
*
11
Recruiting
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Condition(s): Advanced Cancer
*
12
Suspended
Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Condition(s): Endometrial Cancer
*
13
Recruiting
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Condition(s): Renal Cell Carcinoma; Kidney Cancer
*
14
Recruiting
Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
*
15
Recruiting
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
Condition(s): AIPC Prostate Cancer
*
16
Active, not recruiting
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
Condition(s): Metastatic Renal Cell Carcinoma
*
17
Recruiting
Study of Temsirolimus, Topotecan, and Bortezomib
Condition(s): Advanced Cancer
*
18
Active, not recruiting
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Condition(s): Endometrial Cancer; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific
*
19
Recruiting
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Condition(s): Brain and Central Nervous System Tumors
*
20
Recruiting
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Condition(s): Carcinoma, Non-Small-Cell Lung
